1649 |
Current Status of CT for Plaque Evaluation |
Wm. Guy Weigold |
May. 09. 13 |
1648 |
What Is the Role of CT Imaging in Risk Stratification? |
Joon-Won Kang |
May. 09. 13 |
1647 |
WATCHMAN Single Center Experience with Focus on TEE-guided Transseptal Puncture |
Teguh Santoso |
May. 09. 13 |
1646 |
Requirements for a Successful LAAC Program |
Matthew Price |
May. 09. 13 |
1645 |
Place of LAAC in the Era of New OATs |
Horst Sievert |
May. 09. 13 |
1644 |
Latest Update on LAAC and Its Clinical Evidence |
Saibal Kar |
May. 09. 13 |
1643 |
In-Stent Restenosis - Stop ISR: How to Treat DES-ISR?: Summary |
Alan C. Yeung |
May. 09. 13 |
1642 |
Beyond ISR Treatment: Viewpoint of a European DCB Consensus Group |
Franz X. Kleber |
May. 09. 13 |
1641 |
ISAR-DESIRE3: DEB, Desirable Option for DES-ISR |
Adnan Kastrati |
May. 09. 13 |
1640 |
Main Mechanism of DES ISR: Underexpension, Intimal Hyperplasia, Neoatheroscrelosis, Stent Fracture and Malapposition |
Soo-Jin Kang |
May. 09. 13 |